Filing Flows › Utah Medical Products (UTMD) › Capital expenditures
Utah Medical Products (UTMD) capital expenditures by quarter
Utah Medical Products' capital expenditures were $134K in Q2 2026 (second quarter 2026), +3% from Q1 2026. Over the last 7 quarters it ranged from $9K (Q4 2024) to $184K (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $134K | +3% | +163% |
| Q1 2026 | $130K | +19% | -29% |
| Q4 2025 | $109K | +304% | 12× |
| Q3 2025 | $27K | -47% | — |
| Q2 2025 | $51K | -72% | — |
| Q1 2025 | $184K | 20× | — |
| Q4 2024 | $9K | — | — |
Q2 2026 at a glance
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Utah Medical Products' capital expenditures?
Utah Medical Products' capital expenditures were $134K in Q2 2026 (second quarter 2026), +3% from Q1 2026.
How has Utah Medical Products' capital expenditures changed?
Over the last 7 quarters it ranged from $9K (Q4 2024) to $184K (Q1 2025).